HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reposo Ramírez-Lorca Selected Research

N-trifluoroacetyladriamycin

1/2021Evaluation of aquaporins in the cerebrospinal fluid in patients with idiopathic normal pressure hydrocephalus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Reposo Ramírez-Lorca Research Topics

Disease

3Multiple Sclerosis
11/2019 - 07/2014
3Neuromyelitis Optica (Devic's Disease)
11/2019 - 07/2014
3Alzheimer Disease (Alzheimer's Disease)
01/2013 - 07/2011
2Hydrocephalus (Hydrocephaly)
01/2022 - 01/2021
2Nervous System Diseases (Neurological Disorders)
01/2021 - 07/2014
2Neoplasms (Cancer)
01/2019 - 01/2015
2Hypoxia (Hypoxemia)
10/2018 - 01/2016
2Optic Neuritis (Retrobulbar Neuritis)
07/2016 - 07/2014
2Myelitis
07/2016 - 07/2014
2Insulin Resistance
04/2011 - 08/2008
2Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
08/2008 - 01/2007
2Obesity
07/2008 - 01/2007
1Normal Pressure Hydrocephalus
01/2021
1Dementia (Dementias)
01/2021
1Skin Neoplasms (Skin Cancer)
01/2019
1Demyelinating Diseases (Demyelinating Disease)
07/2016
1Cough
01/2011
1Kidney Diseases (Kidney Disease)
01/2011
1Laryngeal Neoplasms (Laryngeal Cancer)
01/2011
1Chronic Cough
01/2011
1Acquired Immunodeficiency Syndrome (AIDS)
10/2008
1Disease Progression
10/2008
1Cardiovascular Diseases (Cardiovascular Disease)
08/2008
1Type 2 Diabetes Mellitus (MODY)
08/2008
1Anovulation
08/2008
1Infertility (Sterility)
08/2008
1Hypertension (High Blood Pressure)
01/2007
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2007
1Hypercholesterolemia
01/2007
1Stroke (Strokes)
05/2004
1Thrombosis (Thrombus)
05/2004

Drug/Important Bio-Agent (IBA)

3Aquaporins (Water Channels)IBA
01/2022 - 10/2018
3Proteins (Proteins, Gene)FDA Link
01/2015 - 05/2004
3Glucose (Dextrose)FDA LinkGeneric
04/2011 - 01/2007
3calpain 10IBA
01/2011 - 01/2007
2Aquaporin 4IBA
01/2021 - 07/2014
2Aquaporin 1IBA
01/2021 - 01/2019
2Immunoglobulin G (IgG)IBA
11/2019 - 07/2016
2AntibodiesIBA
11/2019 - 07/2014
2Insulin (Novolin)FDA Link
04/2011 - 01/2007
1N-trifluoroacetyladriamycinIBA
01/2021
1Myelin-Oligodendrocyte GlycoproteinIBA
11/2019
1Aquaporin 3IBA
01/2019
1Oxygen (Dioxygen)IBA
10/2018
1Octoxynol (Triton X 100)IBA
07/2016
1Bromodeoxyuridine (BrdU)IBA
01/2016
1enhanced green fluorescent proteinIBA
07/2014
1Protein Isoforms (Isoforms)IBA
07/2014
1Natalizumab (Tysabri)FDA Link
07/2014
1PresenilinsIBA
01/2013
1NeuroliginsIBA
01/2013
1Estrogen Receptor alphaIBA
01/2012
1P-2 (P 2)IBA
07/2011
1Complement Receptors (Complement Receptor)IBA
07/2011
1urotensin IIIBA
04/2011
1Substance PIBA
01/2011
1KininsIBA
01/2011
1BradykininIBA
01/2011
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2011
1MMEIBA
01/2011
1Peptide Hydrolases (Proteases)FDA Link
01/2011
1ProstaglandinsIBA
01/2011
1Toll-Like Receptor 9IBA
10/2008
1CholesterolIBA
08/2008
1Genetic Markers (Genetic Marker)IBA
08/2008
1CalpainIBA
07/2008
1PPAR deltaIBA
07/2008
1PPAR gammaIBA
07/2008
1LipidsIBA
01/2007
1Cysteine Proteases (Cysteine Protease)IBA
01/2007
1Vitamin KFDA Link
05/2004

Therapy/Procedure

1Withholding Treatment
01/2011
1Therapeutics
10/2008